Prevención de ictus en pacientes con diabetes mellitus tipo 2 o prediabetes. Recomendaciones del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología-Reference-Cited by-同舟云学术

Prevención de ictus en pacientes con diabetes mellitus tipo 2 o prediabetes. Recomendaciones del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología

Published:2021-05 Issue:4 Volume:36 Page:305-323
ISSN:0213-4853
Container-title:Neurología
language:es
Short-container-title:Neurología

Author:

Fuentes B.,Amaro S.,Alonso de Leciñana M.,Arenillas J.F.,Ayo-Martín O.,Castellanos M.,Freijo M.,García-Pastor A.,Gomis M.,Gómez Choco M.,López-Cancio E.,Martínez Sánchez P.,Morales A.,Palacio-Portilla E.J.,Rodríguez-Yáñez M.,Roquer J.,Segura T.,Serena J.,Vivancos-Mora J.

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference99 articles.

1. Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study;Banerjee;Stroke.,2012

2. A prospective study of fasting plasma glucose and risk of stroke in asymptomatic men;Sui;Mayo Clin Proc.,2011

3. Effect of a multifactorial intervention on mortality in type 2 diabetes;Gaede;N Engl J Med.,2008

4. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association;Meschia;Stroke.,2014

5. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): A case-control study;O’Donnell;Lancet.,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased plasma levels of N-terminal pro-B-type natriuretic peptide as biomarker for the diagnosis of cardioembolic ischaemic stroke;Neurología (English Edition);2024-07

2. N-methyladenosine modification in ischemic stroke: Functions, regulation, and therapeutic potential;Heliyon;2024-02

3. GLP-1 Receptor Agonists and Risk of Adverse Cerebrovascular Outcomes in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;The Journal of Clinical Endocrinology & Metabolism;2023-02-17

4. Benefits of GLP-1 (Glucagon-Like Peptide 1) Receptor Agonists for Stroke Reduction in Type 2 Diabetes: A Call to Action for Neurologists;Stroke;2022-05

5. Increased plasma levels of N-terminal pro-B-type natriuretic peptide as biomarker for the diagnosis of cardioembolic ischaemic stroke;Neurología;2022-01